The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats
We earlier reported that PEGylated liposomes lose their long-circulating property when they are administered twice in the same animal within certain intervals. We recently proposed that anti-PEG IgM elicited by the first dose PEGylated liposomes selectively binds to the surface of a second dose, sub...
Gespeichert in:
Veröffentlicht in: | Journal of controlled release 2008-03, Vol.126 (2), p.162-165 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 165 |
---|---|
container_issue | 2 |
container_start_page | 162 |
container_title | Journal of controlled release |
container_volume | 126 |
creator | Ishida, Tatsuhiro Kashima, Syuntaro Kiwada, Hiroshi |
description | We earlier reported that PEGylated liposomes lose their long-circulating property when they are administered twice in the same animal within certain intervals. We recently proposed that anti-PEG IgM elicited by the first dose PEGylated liposomes selectively binds to the surface of a second dose, subsequently leading to substantial complement activation and complement-receptor mediated uptake of the second dose by hepatic Kupffer cells. In this study we found, by using a single-pass liver perfusion technique, that the first dose does not increase the intrinsic phagocytic activity of the Kupffer cells. It was also found that only serum obtained from rats that had received a first dose is able to enhance the hepatic uptake of test dose. The conditioned-serum-dependent hepatic uptake was completely abolished by pre-treatment of the serum at 56 °C for 30 min, which inhibits the complement activity. Conclusively, our results strongly support our earlier proposal that complement activation caused by anti-PEG IgM elicited by the first dose is a major cause of the initiation of the accelerated blood clearance of a subsequent dose PEGylated liposome in the ABC phenomenon. |
doi_str_mv | 10.1016/j.jconrel.2007.11.009 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70292053</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168365907006323</els_id><sourcerecordid>70292053</sourcerecordid><originalsourceid>FETCH-LOGICAL-c490t-f6d6937f5ef8f4bff81fe3b43c6aee7c96b91b4c9531897e06bae5ec3df283293</originalsourceid><addsrcrecordid>eNqFkcFu3CAYhFHVqNmkfYRWXFqlB7tgbGxOVbJK00iR2kN6Rhj_NKyw2QK70j5FXzl412qPOSAk-Gbgn0HoPSUlJZR_2ZQb7acArqwIaUtKS0LEK7SiXcuKWojmNVplrisYb8Q5uohxQwhpWN2-Qee0o5zQlqzQ38cnwNkoBdvvkvUT9gZvn9Rvrw_Jaqx0snubDvOxs3sIeFQ6-JmAiJPHKeuV1uAgqAQD7p33A9YOVFCTBnx1fbP-nB1h8mNeR_-ft3cHd6Sd3fqYLyK2E84G8S06M8pFeLfsl-jXt9vH9ffi4cfd_fr6odC1IKkwfOCCtaYB05m6N6ajBlhfM80VQKsF7wXtay0aRjvRAuG9ggY0G0zVsUqwS_Tp5LsN_s8OYpKjjXkKpybwuyhbUokqx_UiWFHCGWFtBpsTmOOJMYCR22BHFQ6SEjlXJjdyqUzOlUlKZa4s6z4sD-z6EYb_qqWjDHxcABW1cmbO1cZ_XPbqODmO9PXEQc5tbyHIqC3kDgYbQCc5ePvCV54BTrO59g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21063037</pqid></control><display><type>article</type><title>The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Ishida, Tatsuhiro ; Kashima, Syuntaro ; Kiwada, Hiroshi</creator><creatorcontrib>Ishida, Tatsuhiro ; Kashima, Syuntaro ; Kiwada, Hiroshi</creatorcontrib><description>We earlier reported that PEGylated liposomes lose their long-circulating property when they are administered twice in the same animal within certain intervals. We recently proposed that anti-PEG IgM elicited by the first dose PEGylated liposomes selectively binds to the surface of a second dose, subsequently leading to substantial complement activation and complement-receptor mediated uptake of the second dose by hepatic Kupffer cells. In this study we found, by using a single-pass liver perfusion technique, that the first dose does not increase the intrinsic phagocytic activity of the Kupffer cells. It was also found that only serum obtained from rats that had received a first dose is able to enhance the hepatic uptake of test dose. The conditioned-serum-dependent hepatic uptake was completely abolished by pre-treatment of the serum at 56 °C for 30 min, which inhibits the complement activity. Conclusively, our results strongly support our earlier proposal that complement activation caused by anti-PEG IgM elicited by the first dose is a major cause of the initiation of the accelerated blood clearance of a subsequent dose PEGylated liposome in the ABC phenomenon.</description><identifier>ISSN: 0168-3659</identifier><identifier>EISSN: 1873-4995</identifier><identifier>DOI: 10.1016/j.jconrel.2007.11.009</identifier><identifier>PMID: 18160170</identifier><identifier>CODEN: JCREEC</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Accelerated blood clearance (ABC) phenomenon ; Animals ; Biological and medical sciences ; Complement system ; General pharmacology ; Liposomes ; Liver - cytology ; Liver - drug effects ; Liver - metabolism ; Liver perfusion ; Macrophages - drug effects ; Macrophages - metabolism ; Male ; Medical sciences ; Metabolic Clearance Rate - drug effects ; Metabolic Clearance Rate - physiology ; PEGylated liposome ; Phagocytes - drug effects ; Phagocytes - metabolism ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Polyethylene glycol (PEG) ; Polyethylene Glycols - administration & dosage ; Polyethylene Glycols - pharmacokinetics ; Rats ; Rats, Wistar</subject><ispartof>Journal of controlled release, 2008-03, Vol.126 (2), p.162-165</ispartof><rights>2007 Elsevier B.V.</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c490t-f6d6937f5ef8f4bff81fe3b43c6aee7c96b91b4c9531897e06bae5ec3df283293</citedby><cites>FETCH-LOGICAL-c490t-f6d6937f5ef8f4bff81fe3b43c6aee7c96b91b4c9531897e06bae5ec3df283293</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0168365907006323$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20086029$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18160170$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ishida, Tatsuhiro</creatorcontrib><creatorcontrib>Kashima, Syuntaro</creatorcontrib><creatorcontrib>Kiwada, Hiroshi</creatorcontrib><title>The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats</title><title>Journal of controlled release</title><addtitle>J Control Release</addtitle><description>We earlier reported that PEGylated liposomes lose their long-circulating property when they are administered twice in the same animal within certain intervals. We recently proposed that anti-PEG IgM elicited by the first dose PEGylated liposomes selectively binds to the surface of a second dose, subsequently leading to substantial complement activation and complement-receptor mediated uptake of the second dose by hepatic Kupffer cells. In this study we found, by using a single-pass liver perfusion technique, that the first dose does not increase the intrinsic phagocytic activity of the Kupffer cells. It was also found that only serum obtained from rats that had received a first dose is able to enhance the hepatic uptake of test dose. The conditioned-serum-dependent hepatic uptake was completely abolished by pre-treatment of the serum at 56 °C for 30 min, which inhibits the complement activity. Conclusively, our results strongly support our earlier proposal that complement activation caused by anti-PEG IgM elicited by the first dose is a major cause of the initiation of the accelerated blood clearance of a subsequent dose PEGylated liposome in the ABC phenomenon.</description><subject>Accelerated blood clearance (ABC) phenomenon</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Complement system</subject><subject>General pharmacology</subject><subject>Liposomes</subject><subject>Liver - cytology</subject><subject>Liver - drug effects</subject><subject>Liver - metabolism</subject><subject>Liver perfusion</subject><subject>Macrophages - drug effects</subject><subject>Macrophages - metabolism</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Metabolic Clearance Rate - drug effects</subject><subject>Metabolic Clearance Rate - physiology</subject><subject>PEGylated liposome</subject><subject>Phagocytes - drug effects</subject><subject>Phagocytes - metabolism</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Polyethylene glycol (PEG)</subject><subject>Polyethylene Glycols - administration & dosage</subject><subject>Polyethylene Glycols - pharmacokinetics</subject><subject>Rats</subject><subject>Rats, Wistar</subject><issn>0168-3659</issn><issn>1873-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFu3CAYhFHVqNmkfYRWXFqlB7tgbGxOVbJK00iR2kN6Rhj_NKyw2QK70j5FXzl412qPOSAk-Gbgn0HoPSUlJZR_2ZQb7acArqwIaUtKS0LEK7SiXcuKWojmNVplrisYb8Q5uohxQwhpWN2-Qee0o5zQlqzQ38cnwNkoBdvvkvUT9gZvn9Rvrw_Jaqx0snubDvOxs3sIeFQ6-JmAiJPHKeuV1uAgqAQD7p33A9YOVFCTBnx1fbP-nB1h8mNeR_-ft3cHd6Sd3fqYLyK2E84G8S06M8pFeLfsl-jXt9vH9ffi4cfd_fr6odC1IKkwfOCCtaYB05m6N6ajBlhfM80VQKsF7wXtay0aRjvRAuG9ggY0G0zVsUqwS_Tp5LsN_s8OYpKjjXkKpybwuyhbUokqx_UiWFHCGWFtBpsTmOOJMYCR22BHFQ6SEjlXJjdyqUzOlUlKZa4s6z4sD-z6EYb_qqWjDHxcABW1cmbO1cZ_XPbqODmO9PXEQc5tbyHIqC3kDgYbQCc5ePvCV54BTrO59g</recordid><startdate>20080303</startdate><enddate>20080303</enddate><creator>Ishida, Tatsuhiro</creator><creator>Kashima, Syuntaro</creator><creator>Kiwada, Hiroshi</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7T5</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20080303</creationdate><title>The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats</title><author>Ishida, Tatsuhiro ; Kashima, Syuntaro ; Kiwada, Hiroshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c490t-f6d6937f5ef8f4bff81fe3b43c6aee7c96b91b4c9531897e06bae5ec3df283293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Accelerated blood clearance (ABC) phenomenon</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Complement system</topic><topic>General pharmacology</topic><topic>Liposomes</topic><topic>Liver - cytology</topic><topic>Liver - drug effects</topic><topic>Liver - metabolism</topic><topic>Liver perfusion</topic><topic>Macrophages - drug effects</topic><topic>Macrophages - metabolism</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Metabolic Clearance Rate - drug effects</topic><topic>Metabolic Clearance Rate - physiology</topic><topic>PEGylated liposome</topic><topic>Phagocytes - drug effects</topic><topic>Phagocytes - metabolism</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Polyethylene glycol (PEG)</topic><topic>Polyethylene Glycols - administration & dosage</topic><topic>Polyethylene Glycols - pharmacokinetics</topic><topic>Rats</topic><topic>Rats, Wistar</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ishida, Tatsuhiro</creatorcontrib><creatorcontrib>Kashima, Syuntaro</creatorcontrib><creatorcontrib>Kiwada, Hiroshi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of controlled release</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ishida, Tatsuhiro</au><au>Kashima, Syuntaro</au><au>Kiwada, Hiroshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats</atitle><jtitle>Journal of controlled release</jtitle><addtitle>J Control Release</addtitle><date>2008-03-03</date><risdate>2008</risdate><volume>126</volume><issue>2</issue><spage>162</spage><epage>165</epage><pages>162-165</pages><issn>0168-3659</issn><eissn>1873-4995</eissn><coden>JCREEC</coden><abstract>We earlier reported that PEGylated liposomes lose their long-circulating property when they are administered twice in the same animal within certain intervals. We recently proposed that anti-PEG IgM elicited by the first dose PEGylated liposomes selectively binds to the surface of a second dose, subsequently leading to substantial complement activation and complement-receptor mediated uptake of the second dose by hepatic Kupffer cells. In this study we found, by using a single-pass liver perfusion technique, that the first dose does not increase the intrinsic phagocytic activity of the Kupffer cells. It was also found that only serum obtained from rats that had received a first dose is able to enhance the hepatic uptake of test dose. The conditioned-serum-dependent hepatic uptake was completely abolished by pre-treatment of the serum at 56 °C for 30 min, which inhibits the complement activity. Conclusively, our results strongly support our earlier proposal that complement activation caused by anti-PEG IgM elicited by the first dose is a major cause of the initiation of the accelerated blood clearance of a subsequent dose PEGylated liposome in the ABC phenomenon.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>18160170</pmid><doi>10.1016/j.jconrel.2007.11.009</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0168-3659 |
ispartof | Journal of controlled release, 2008-03, Vol.126 (2), p.162-165 |
issn | 0168-3659 1873-4995 |
language | eng |
recordid | cdi_proquest_miscellaneous_70292053 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Accelerated blood clearance (ABC) phenomenon Animals Biological and medical sciences Complement system General pharmacology Liposomes Liver - cytology Liver - drug effects Liver - metabolism Liver perfusion Macrophages - drug effects Macrophages - metabolism Male Medical sciences Metabolic Clearance Rate - drug effects Metabolic Clearance Rate - physiology PEGylated liposome Phagocytes - drug effects Phagocytes - metabolism Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Polyethylene glycol (PEG) Polyethylene Glycols - administration & dosage Polyethylene Glycols - pharmacokinetics Rats Rats, Wistar |
title | The contribution of phagocytic activity of liver macrophages to the accelerated blood clearance (ABC) phenomenon of PEGylated liposomes in rats |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T21%3A36%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20contribution%20of%20phagocytic%20activity%20of%20liver%20macrophages%20to%20the%20accelerated%20blood%20clearance%20(ABC)%20phenomenon%20of%20PEGylated%20liposomes%20in%20rats&rft.jtitle=Journal%20of%20controlled%20release&rft.au=Ishida,%20Tatsuhiro&rft.date=2008-03-03&rft.volume=126&rft.issue=2&rft.spage=162&rft.epage=165&rft.pages=162-165&rft.issn=0168-3659&rft.eissn=1873-4995&rft.coden=JCREEC&rft_id=info:doi/10.1016/j.jconrel.2007.11.009&rft_dat=%3Cproquest_cross%3E70292053%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=21063037&rft_id=info:pmid/18160170&rft_els_id=S0168365907006323&rfr_iscdi=true |